An investigation of the apparent breast cancer epidemic in France: screening and incidence trends in birth cohorts

Abstract

BackgroundOfficial descriptive data from France showed a strong increase in breast-cancer incidence between 1980 to 2005 without a corresponding change in breast-cancer mortality. This study quantifies the part of incidence increase due to secular changes in risk factor exposure and in overdiagnosis due to organised or opportunistic screening. Overdiagnosis was defined as non progressive tumours diagnosed as cancer at histology or progressive cancer that would remain asymptomatic until time of death for another cause.MethodsComparison between age-matched cohorts from 1980 to 2005. All women residing in France and born 1911-1915, 1926-1930 and 1941-1945 are included. Sources are official data sets and published French reports on screening by mammography, age and time specific breast-cancer incidence and mortality, hormone replacement therapy, alcohol and obesity. Outcome measures include breast-cancer incidence differences adjusted for changes in risk factor distributions between pairs of age-matched cohorts who had experienced different levels of screening intensity.ResultsThere was an 8-fold increase in the number of mammography machines operating in France between 1980 and 2000. Opportunistic and organised screening increased over time. In comparison to age-matched cohorts born 15 years earlier, recent cohorts had adjusted incidence proportion over 11 years that were 76% higher [95% confidence limits (CL) 67%, 85%] for women aged 50 to 64 years and 23% higher [95% CL 15%, 31%] for women aged 65 to 79 years. Given that mortality did not change correspondingly, this increase in adjusted 11 year incidence proportion was considered as an estimate of overdiagnosis.ConclusionsBreast cancer may be overdiagnosed because screening increases diagnosis of slowly progressing non-life threatening cancer and increases misdiagnosis among women without progressive cancer. We suggest that these effects could largely explain the reported "epidemic" of breast cancer in France. Better predictive classification of tumours is needed in order to avoid unnecessary cancer diagnoses and subsequent procedures.

Breast Cancer Incidence After Risk-Reducing Salpingo-Oophorectomy in BRCA1 and BRCA2 Mutation Carriers

“…Warner and colleagues found a higher incidence of breast cancer in the first 3 years after the introduction of MRI screening in BRCA1/2 mutation carriers and an overall higher incidence of DCIS (26). This effect has also been shown in the general population after introduction of the population-based breast cancer screening with mammography (27,28). This explanation is weakened by the fact that this effect was not seen in BRCA2 mutation carriers.…”

Effectiveness of Water Physical Therapy on Pain, Pressure Pain Sensitivity, and Myofascial Trigger Points in Breast Cancer Survivors: A Randomized, Controlled Clinical Trial

“…A case‐control study determined that the total average costs of breast cancer was 107,456€/patient, being 89% productivity loss costs and 11% health care costs [4]. Different studies have investigated the incidence and prevalence rates of breast cancer; however, it has been recently reported that incidence rates of breast cancer have been overestimated in the last decade [5,6]. In fact, a recent report has shown that breast cancer mortality has decreased in Europe over the last 25–30 years [7].…”

Immediate and delayed effects of mammographic screening on breast cancer mortality and incidence in birth cohorts

“…This is a well-known phenomenon, which has been demonstrated in studies displaying age–cohort graphics (Brown et al , 2009; Martinez-Alonso et al , 2010; Junod et al , 2011) or age–period graphics (Svendsen et al , 2006; Otten et al , 2008; Pollán et al , 2010). …”